2023-12-05 08:28:55 ET
- Losers: Replimune Group ( REPL ) -50% presents new data from IGNYTE clinical trial of RP1 in Anti-PD1 failed Melanoma and non-Melanoma skin cancers.
- iBio ( IBIO ) -38% announces pricing of $4.5 Million public offering .
- Designer Brands ( DBI ) -33% after Q3 earning release .
- SilverSun Technologies ( SSNT ) -28% .
- Alterity Therapeutics Ltd ( ATHE ) -20% to host webcast to discuss ATH434 efficacy data in primates and recent clinical progress.
- Mesoblast Ltd ( MESO ) -15% .
- Daktronics ( DAKT ) -14% after Q2 earning release .
- Ampio Pharmaceuticals ( AMPE ) -14% .
- Millennium Group International Holdings ( MGIH ) -13% .
- Sphere Entertainment Co SPHR -12% to offer $225M worth of convertible senior notes .
- Fenbo Holdings ( FEBO ) -12% .
- Argo Blockchain Plc ( ARBK ) -10% .
- Neximmune ( NEXI ) -9% .
- Smart for Life ( SMFL ) -9% .
- Bit Origin Ltd ( BTOG ) -8% .
- Evolent Health ( EVH ) -8% to offer $350M worth of convertible senior notes .
- Clearmind Medicine ( CMND ) -5% .
- Nokia Corp ( NOK ) -7% . AT&T picks Ericsson over Nokia for $14B Open RAN contract .
- Safe and Green Development Corp ( SGD ) -7% .
- SpringWorks Therapeutics ( SWTX ) -5% announces pricing of upsized public offering of common stock.
- Golden Ocean Group Limited ( GOGL ) -5% .
- Seelos Therapeutics ( SEEL ) -6% .
For further details see:
SSNT, MESO and AMPE among pre-market losers